BIOMAT Database Logo BIOMAT Database Logo

Evaluation of a new preservation solution containing fosfomycin for 20-hour canine lung preservation. 2001

Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
First Department of Surgery, Tokyo Medical University, Tokyo, Japan.

UI MeSH Term Description Entries
D006982 Hypertonic Solutions Solutions that have a greater osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid. Hypertonic Solution,Solution, Hypertonic,Solutions, Hypertonic
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010313 Partial Pressure The pressure that would be exerted by one component of a mixture of gases if it were present alone in a container. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Partial Pressures,Pressure, Partial,Pressures, Partial
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005578 Fosfomycin An antibiotic produced by Streptomyces fradiae. Phosphonomycin,Fosfomycin Trometamol Salt,Fosfomycin Tromethamine,Monuril,Phosphomycin,Tromethamine, Fosfomycin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
Evaluation of a new solution containing trehalose for twenty-hour canine lung preservation.
January 1996, Transplant international : official journal of the European Society for Organ Transplantation,
Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
Improved 20-hour canine lung preservation with a new solution--ET-Kyoto solution.
January 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
Effects of ET-Kyoto solution on 20-hour canine lung preservation.
April 1994, Transplantation proceedings,
Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
ET-Kyoto solution for 48-hour canine lung preservation.
March 1996, The Annals of thoracic surgery,
Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
Twenty-four-hour canine lung preservation using UW solution.
March 1991, Transplantation,
Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
New ET-Kyoto solution containing N-acetylcysteine, nitroglycerin, and dibutyryl cyclic AMP provides reliable 30-hour canine lung preservation.
June 1996, Transplantation proceedings,
Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
Newly developed preservation solution for the lung: 30-hour preservation with new ET-Kyoto solution.
June 1996, Transplantation proceedings,
Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
Twenty-hour canine lung preservation using newly developed solutions containing trehalose.
April 1994, Transplantation proceedings,
Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation.
March 1993, The Journal of thoracic and cardiovascular surgery,
Y Nagatsuka, and S Nakajima, and K Ogata, and M Takahashi, and O Uchida, and C Konaka, and H Kato
A newly developed solution enhances thirty-hour preservation in a canine lung transplantation model.
September 1996, The Journal of thoracic and cardiovascular surgery,
Copied contents to your clipboard!